These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 25591478

  • 1. The kappa-opioid receptor antagonist, nor-binaltorphimine (nor-BNI), decreases morphine withdrawal and the consequent conditioned place aversion in rats.
    Kelsey JE, Verhaak AM, Schierberl KC.
    Behav Brain Res; 2015 Apr 15; 283():16-21. PubMed ID: 25591478
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence.
    Walker BM, Koob GF.
    Neuropsychopharmacology; 2008 Feb 15; 33(3):643-52. PubMed ID: 17473837
    [Abstract] [Full Text] [Related]

  • 4. Effects of pharmacological manipulation of the kappa opioid receptors on the aversive effects of nicotine.
    Ward M, Norman H, D'Souza MS.
    Behav Brain Res; 2018 Feb 15; 338():56-65. PubMed ID: 29037662
    [Abstract] [Full Text] [Related]

  • 5. Upregulation of dynorphin/kappa opioid receptor system in the dorsal hippocampus contributes to morphine withdrawal-induced place aversion.
    Chen Y, Wang CY, Zan GY, Yao SY, Deng YZ, Shu XL, Wu WW, Ma Y, Wang YJ, Yu CX, Liu JG.
    Acta Pharmacol Sin; 2023 Mar 15; 44(3):538-545. PubMed ID: 36127507
    [Abstract] [Full Text] [Related]

  • 6. Inhibitory effects of processed Aconiti tuber on morphine-induced conditioned place preference in rats.
    Wu G, Huang W, Zhang H, Li Q, Zhou J, Shu H.
    J Ethnopharmacol; 2011 Jun 14; 136(1):254-9. PubMed ID: 21549821
    [Abstract] [Full Text] [Related]

  • 7. The involvement of CRF1 receptor within the basolateral amygdala and dentate gyrus in the naloxone-induced conditioned place aversion in morphine-dependent mice.
    Valero E, Gómez-Milanés I, Almela P, Ribeiro Do Couto B, Laorden ML, Milanés MV, Núñez C.
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun 08; 84(Pt A):102-114. PubMed ID: 29407532
    [Abstract] [Full Text] [Related]

  • 8. The unconditioned fear produced by morphine withdrawal is regulated by mu- and kappa-opioid receptors in the midbrain tectum.
    De Ross J, Avila MA, Ruggiero RN, Nobre MJ, Brandão ML, Castilho VM.
    Behav Brain Res; 2009 Dec 01; 204(1):140-6. PubMed ID: 19520121
    [Abstract] [Full Text] [Related]

  • 9. Endogenous kappa-opioid systems in opiate withdrawal: role in aversion and accompanying changes in mesolimbic dopamine release.
    Spanagel R, Almeida OF, Bartl C, Shippenberg TS.
    Psychopharmacology (Berl); 1994 Jun 01; 115(1-2):121-7. PubMed ID: 7862883
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
    Stinus L, Cador M, Zorrilla EP, Koob GF.
    Neuropsychopharmacology; 2005 Jan 01; 30(1):90-8. PubMed ID: 15138444
    [Abstract] [Full Text] [Related]

  • 12. Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal.
    Azar MR, Jones BC, Schulteis G.
    Psychopharmacology (Berl); 2003 Oct 01; 170(1):42-50. PubMed ID: 12783156
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Protracted withdrawal from ethanol and enhanced responsiveness stress: regulation via the dynorphin/kappa opioid receptor system.
    Gillett K, Harshberger E, Valdez GR.
    Alcohol; 2013 Aug 01; 47(5):359-65. PubMed ID: 23731692
    [Abstract] [Full Text] [Related]

  • 16. Morphine withdrawal precipitated by specific mu, delta or kappa opioid receptor antagonists: a c-Fos protein study in the rat central nervous system.
    Le Guen S, Gestreau C, Besson JM.
    Eur J Neurosci; 2003 Jun 01; 17(11):2425-37. PubMed ID: 12814374
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Spinal kappa-opioid system plays an important role in suppressing morphine withdrawal syndrome in the rat.
    Cui CL, Wu LZ, Han JS.
    Neurosci Lett; 2000 Dec 01; 295(1-2):45-8. PubMed ID: 11078933
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.